The interleukin-4 expression in patients with severe sepsis

Sepsis is a complicated syndrome in which proinflammatory and anti-inflammatory cytokines are expressed simultaneously. However, it remains unclear for the expression of interleukin (IL)–4 and IL-4 δ2 in patients with severe sepsis. By nested reverse transcriptase–polymerase chain reaction and the e...

Full description

Saved in:
Bibliographic Details
Published inJournal of critical care Vol. 23; no. 4; pp. 519 - 524
Main Authors Wu, Huang-Pin, Wu, Chia-Ling, Chen, Chian-Kuang, Chung, Kong, Tseng, Jo-Chi, Liu, Yu-Chih, Chuang, Duen-Yau
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.12.2008
Elsevier Limited
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Sepsis is a complicated syndrome in which proinflammatory and anti-inflammatory cytokines are expressed simultaneously. However, it remains unclear for the expression of interleukin (IL)–4 and IL-4 δ2 in patients with severe sepsis. By nested reverse transcriptase–polymerase chain reaction and the expression of glyceraldehydes-3-phosphate dehydrogenase as the internal reference, the expression levels of IL-4 and IL-4 δ2 were determined in peripheral blood mononuclear cells (PBMCs) of 76 patients with severe sepsis and were immediately admitted to an intensive care unit. Plasma IL-4 level was measured by enzyme-linked immunosorbent assay. Clinical characteristics were monitored and recorded prospectively. The IL-4 messenger RNA (mRNA) expression in PBMCs of patients who had survived was significantly higher than that of those who had died. The IL-4 δ2/IL-4 ratio in PBMCs of patients who had survived was significantly lower than that of those who had died. The IL-4 δ2 expression did not differ between survivors and nonsurvivors. After regression analysis, the IL-4 δ2/IL-4 ratio still was an independent factor for death in patients with severe sepsis. The expression of IL-4 δ2 mRNA was positively correlated with that of IL-4 mRNA in patients with severe sepsis. The plasma IL-4 levels in septic patients on admission day did not differ between survivors and nonsurvivors. The IL-4 mRNA expression might be associated with survival in patients with severe sepsis. The IL-4 δ2/IL-4 ratio might be served as the net immunity of IL-4 activity.
AbstractList Sepsis is a complicated syndrome in which proinflammatory and anti-inflammatory cytokines are expressed simultaneously. However, it remains unclear for the expression of interleukin (IL)–4 and IL-4 δ2 in patients with severe sepsis. By nested reverse transcriptase–polymerase chain reaction and the expression of glyceraldehydes-3-phosphate dehydrogenase as the internal reference, the expression levels of IL-4 and IL-4 δ2 were determined in peripheral blood mononuclear cells (PBMCs) of 76 patients with severe sepsis and were immediately admitted to an intensive care unit. Plasma IL-4 level was measured by enzyme-linked immunosorbent assay. Clinical characteristics were monitored and recorded prospectively. The IL-4 messenger RNA (mRNA) expression in PBMCs of patients who had survived was significantly higher than that of those who had died. The IL-4 δ2/IL-4 ratio in PBMCs of patients who had survived was significantly lower than that of those who had died. The IL-4 δ2 expression did not differ between survivors and nonsurvivors. After regression analysis, the IL-4 δ2/IL-4 ratio still was an independent factor for death in patients with severe sepsis. The expression of IL-4 δ2 mRNA was positively correlated with that of IL-4 mRNA in patients with severe sepsis. The plasma IL-4 levels in septic patients on admission day did not differ between survivors and nonsurvivors. The IL-4 mRNA expression might be associated with survival in patients with severe sepsis. The IL-4 δ2/IL-4 ratio might be served as the net immunity of IL-4 activity.
Sepsis is a complicated syndrome in which proinflammatory and anti-inflammatory cytokines are expressed simultaneously. However, it remains unclear for the expression of interleukin (IL)-4 and IL-4δ 2 in patients with severe sepsis. By nested reverse transcriptase-polymerase chain reaction and the expression of glyceraldehydes-3-phosphate dehydrogenase as the internal reference, the expression levels of IL-4 and IL-4δ 2 were determined in peripheral blood mononuclear cells (PBMCs) of 76 patients with severe sepsis and were immediately admitted to an intensive care unit. Plasma IL-4 level was measured by enzyme-linked immunosorbent assay. Clinical characteristics were monitored and recorded prospectively. The IL-4 messenger RNA (mRNA) expression in PBMCs of patients who had survived was significantly higher than that of those who had died. The IL-4δ 2/IL-4 ratio in PBMCs of patients who had survived was significantly lower than that of those who had died. The IL-4δ 2 expression did not differ between survivors and nonsurvivors. After regression analysis, the IL-4δ 2/IL-4 ratio still was an independent factor for death in patients with severe sepsis. The expression of IL-4δ 2 mRNA was positively correlated with that of IL-4 mRNA in patients with severe sepsis. The plasma IL-4 levels in septic patients on admission day did not differ between survivors and nonsurvivors. The IL-4 mRNA expression might be associated with survival in patients with severe sepsis. The IL-4δ 2/IL-4 ratio might be served as the net immunity of IL-4 activity.
Abstract Purpose Sepsis is a complicated syndrome in which proinflammatory and anti-inflammatory cytokines are expressed simultaneously. However, it remains unclear for the expression of interleukin (IL)–4 and IL-4 δ 2 in patients with severe sepsis. Materials and Methods By nested reverse transcriptase–polymerase chain reaction and the expression of glyceraldehydes-3-phosphate dehydrogenase as the internal reference, the expression levels of IL-4 and IL-4 δ 2 were determined in peripheral blood mononuclear cells (PBMCs) of 76 patients with severe sepsis and were immediately admitted to an intensive care unit. Plasma IL-4 level was measured by enzyme-linked immunosorbent assay. Clinical characteristics were monitored and recorded prospectively. Results The IL-4 messenger RNA (mRNA) expression in PBMCs of patients who had survived was significantly higher than that of those who had died. The IL-4 δ 2/IL-4 ratio in PBMCs of patients who had survived was significantly lower than that of those who had died. The IL-4 δ 2 expression did not differ between survivors and nonsurvivors. After regression analysis, the IL-4 δ 2/IL-4 ratio still was an independent factor for death in patients with severe sepsis. The expression of IL-4 δ 2 mRNA was positively correlated with that of IL-4 mRNA in patients with severe sepsis. The plasma IL-4 levels in septic patients on admission day did not differ between survivors and nonsurvivors. Conclusions The IL-4 mRNA expression might be associated with survival in patients with severe sepsis. The IL-4 δ 2/IL-4 ratio might be served as the net immunity of IL-4 activity.
Sepsis is a complicated syndrome in which proinflammatory and anti-inflammatory cytokines are expressed simultaneously. However, it remains unclear for the expression of interleukin (IL)-4 and IL-4delta2 in patients with severe sepsis.PURPOSESepsis is a complicated syndrome in which proinflammatory and anti-inflammatory cytokines are expressed simultaneously. However, it remains unclear for the expression of interleukin (IL)-4 and IL-4delta2 in patients with severe sepsis.By nested reverse transcriptase-polymerase chain reaction and the expression of glyceraldehydes-3-phosphate dehydrogenase as the internal reference, the expression levels of IL-4 and IL-4delta2 were determined in peripheral blood mononuclear cells (PBMCs) of 76 patients with severe sepsis and were immediately admitted to an intensive care unit. Plasma IL-4 level was measured by enzyme-linked immunosorbent assay. Clinical characteristics were monitored and recorded prospectively.MATERIALS AND METHODSBy nested reverse transcriptase-polymerase chain reaction and the expression of glyceraldehydes-3-phosphate dehydrogenase as the internal reference, the expression levels of IL-4 and IL-4delta2 were determined in peripheral blood mononuclear cells (PBMCs) of 76 patients with severe sepsis and were immediately admitted to an intensive care unit. Plasma IL-4 level was measured by enzyme-linked immunosorbent assay. Clinical characteristics were monitored and recorded prospectively.The IL-4 messenger RNA (mRNA) expression in PBMCs of patients who had survived was significantly higher than that of those who had died. The IL-4delta2/IL-4 ratio in PBMCs of patients who had survived was significantly lower than that of those who had died. The IL-4delta2 expression did not differ between survivors and nonsurvivors. After regression analysis, the IL-4delta2/IL-4 ratio still was an independent factor for death in patients with severe sepsis. The expression of IL-4delta2 mRNA was positively correlated with that of IL-4 mRNA in patients with severe sepsis. The plasma IL-4 levels in septic patients on admission day did not differ between survivors and nonsurvivors.RESULTSThe IL-4 messenger RNA (mRNA) expression in PBMCs of patients who had survived was significantly higher than that of those who had died. The IL-4delta2/IL-4 ratio in PBMCs of patients who had survived was significantly lower than that of those who had died. The IL-4delta2 expression did not differ between survivors and nonsurvivors. After regression analysis, the IL-4delta2/IL-4 ratio still was an independent factor for death in patients with severe sepsis. The expression of IL-4delta2 mRNA was positively correlated with that of IL-4 mRNA in patients with severe sepsis. The plasma IL-4 levels in septic patients on admission day did not differ between survivors and nonsurvivors.The IL-4 mRNA expression might be associated with survival in patients with severe sepsis. The IL-4delta2/IL-4 ratio might be served as the net immunity of IL-4 activity.CONCLUSIONSThe IL-4 mRNA expression might be associated with survival in patients with severe sepsis. The IL-4delta2/IL-4 ratio might be served as the net immunity of IL-4 activity.
Sepsis is a complicated syndrome in which proinflammatory and anti-inflammatory cytokines are expressed simultaneously. However, it remains unclear for the expression of interleukin (IL)-4 and IL-4delta2 in patients with severe sepsis. By nested reverse transcriptase-polymerase chain reaction and the expression of glyceraldehydes-3-phosphate dehydrogenase as the internal reference, the expression levels of IL-4 and IL-4delta2 were determined in peripheral blood mononuclear cells (PBMCs) of 76 patients with severe sepsis and were immediately admitted to an intensive care unit. Plasma IL-4 level was measured by enzyme-linked immunosorbent assay. Clinical characteristics were monitored and recorded prospectively. The IL-4 messenger RNA (mRNA) expression in PBMCs of patients who had survived was significantly higher than that of those who had died. The IL-4delta2/IL-4 ratio in PBMCs of patients who had survived was significantly lower than that of those who had died. The IL-4delta2 expression did not differ between survivors and nonsurvivors. After regression analysis, the IL-4delta2/IL-4 ratio still was an independent factor for death in patients with severe sepsis. The expression of IL-4delta2 mRNA was positively correlated with that of IL-4 mRNA in patients with severe sepsis. The plasma IL-4 levels in septic patients on admission day did not differ between survivors and nonsurvivors. The IL-4 mRNA expression might be associated with survival in patients with severe sepsis. The IL-4delta2/IL-4 ratio might be served as the net immunity of IL-4 activity.
Author Wu, Huang-Pin
Chen, Chian-Kuang
Liu, Yu-Chih
Chuang, Duen-Yau
Chung, Kong
Wu, Chia-Ling
Tseng, Jo-Chi
Author_xml – sequence: 1
  givenname: Huang-Pin
  surname: Wu
  fullname: Wu, Huang-Pin
  organization: Division of Pulmonary Medicine, Department of Internal Medicine, Chang Gung Memorial Hospital, Keelung 204, Taiwan, ROC
– sequence: 2
  givenname: Chia-Ling
  surname: Wu
  fullname: Wu, Chia-Ling
  organization: Department of Chemistry, National Chung-Hsing University, Taichung 402, Taiwan, ROC
– sequence: 3
  givenname: Chian-Kuang
  surname: Chen
  fullname: Chen, Chian-Kuang
  organization: Chang Gung University College of Medicine, Taoyuan 333, Taiwan, ROC
– sequence: 4
  givenname: Kong
  surname: Chung
  fullname: Chung, Kong
  organization: Chang Gung University College of Medicine, Taoyuan 333, Taiwan, ROC
– sequence: 5
  givenname: Jo-Chi
  surname: Tseng
  fullname: Tseng, Jo-Chi
  organization: Division of Pulmonary Medicine, Department of Internal Medicine, Chang Gung Memorial Hospital, Keelung 204, Taiwan, ROC
– sequence: 6
  givenname: Yu-Chih
  surname: Liu
  fullname: Liu, Yu-Chih
  organization: Division of Pulmonary Medicine, Department of Internal Medicine, Chang Gung Memorial Hospital, Keelung 204, Taiwan, ROC
– sequence: 7
  givenname: Duen-Yau
  surname: Chuang
  fullname: Chuang, Duen-Yau
  email: chuang@dragon.nchu.edu.tw
  organization: Department of Chemistry, National Chung-Hsing University, Taichung 402, Taiwan, ROC
BackLink https://www.ncbi.nlm.nih.gov/pubmed/19056016$$D View this record in MEDLINE/PubMed
BookMark eNqFkl1L3jAYhoM49NX5BzwYhcHO2iVN81E3BkPmBwge6I5Dmj7F1L5pTVI3__1SXjfhhenRc_Dc151w8RygXTc6QOiY4IJgwj_3RW-8KUqMRUFIgbHcQSvCmMglJ2wXrbCUNK-riuyjgxB6jImglO2hfVJjxlPFCn25vYPMugh-gPneurzK4PfkIQQ7urTIJh0tuBiyXzbeZQEewUMaU7DhPXrX6SHA0fM8RD_PftyeXuRX1-eXp9-vclNJGXMjdc0pE1xq1soKV6TRRkvOmSC8YWUpMe-atmOdrFqopeaMi050ZUUb07SUHqJPm97Jjw8zhKjWNhgYBu1gnIPitRS4LnEKftwK9uPsXfqbIpjSkgoqeUp9eE7NzRpaNXm71v5J_ZWSAnITMH4MwUOnjI1Jw-ii13ZIXWrxr3q1-FeLf0WISv4TWm6h_9pfg75uIEgSHy14FUxybqC1HkxU7Whfx79t4Wawzho93MMThBcFKpQKq5vlKpajwCIdRM1YKjj5f8Fbr_8BZmrFBg
CitedBy_id crossref_primary_10_1016_j_cgh_2019_08_036
crossref_primary_10_3892_etm_2016_3354
crossref_primary_10_1016_j_cyto_2017_09_007
crossref_primary_10_1007_s00740_015_0064_3
crossref_primary_10_1155_2013_165974
crossref_primary_10_1055_a_2114_8333
crossref_primary_10_1016_j_cyto_2011_12_017
crossref_primary_10_1016_j_tria_2022_100170
crossref_primary_10_1055_a_1813_2057
crossref_primary_10_5607_en_2018_27_4_309
crossref_primary_10_1097_ALN_0000000000001031
crossref_primary_10_1089_jir_2014_0119
crossref_primary_10_4161_epi_6_3_14017
crossref_primary_10_1097_TA_0b013e3182115034
crossref_primary_10_1007_s10753_015_0135_z
crossref_primary_10_1111_j_1365_2567_2010_03393_x
crossref_primary_10_17650_1818_8346_2024_19_4_182_187
crossref_primary_10_1016_j_ccc_2017_08_002
crossref_primary_10_1007_s10096_014_2275_8
crossref_primary_10_1155_2014_269681
crossref_primary_10_1189_jlb_0412214
crossref_primary_10_1055_a_2181_1018
crossref_primary_10_1016_j_ejphar_2023_176043
crossref_primary_10_3892_ijo_2019_4862
crossref_primary_10_1189_jlb_0510271
crossref_primary_10_1016_j_intimp_2018_03_005
crossref_primary_10_1089_jir_2014_0107
crossref_primary_10_1007_s00101_014_2402_z
crossref_primary_10_56986_pim_2023_06_005
crossref_primary_10_1016_j_jprot_2012_05_018
Cites_doi 10.1097/00003246-198510000-00009
10.1164/ajrccm.164.6.2012138
10.1006/cimm.1998.1431
10.1056/NEJMra043632
10.1016/0161-5890(95)00154-9
10.4049/jimmunol.156.2.435
10.4049/jimmunol.172.11.6938
10.1385/IR:24:3:273
10.1067/msy.2000.107282
10.1002/(SICI)1521-4141(199802)28:02<610::AID-IMMU610>3.0.CO;2-5
10.1006/jsre.2002.6417
10.1016/j.tube.2006.11.001
10.1056/NEJMra021333
10.1016/S0014-4835(02)00248-8
10.1097/01.CCM.0000050454.01978.3B
10.1378/chest.111.5.1306
10.1136/thorax.56.7.541
10.1097/01.shk.0000068322.08268.b4
10.1002/(SICI)1521-4141(199908)29:08<2400::AID-IMMU2400>3.0.CO;2-E
10.1097/00003246-199510000-00007
10.1001/archsurg.1995.01430110017004
ContentType Journal Article
Copyright 2008 Elsevier Inc.
Elsevier Inc.
Copyright_xml – notice: 2008 Elsevier Inc.
– notice: Elsevier Inc.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7RV
7X7
7XB
88E
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AN0
ASE
AZQEC
BENPR
CCPQU
DWQXO
FPQ
FYUFA
GHDGH
GNUQQ
GUQSH
K6X
K9.
KB0
M0S
M1P
M2O
MBDVC
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
Q9U
7X8
DOI 10.1016/j.jcrc.2007.11.008
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Nursing & Allied Health Database
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Research Library
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
British Nursing Database (Proquest)
British Nursing Index
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
British Nursing Index (BNI) (1985 to Present)
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
Research Library Prep
British Nursing Index
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Health & Medical Collection (Alumni)
Medical Database
Research Library
Research Library (Corporate)
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central Basic
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Research Library Prep
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Research Library
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Central Basic
ProQuest One Academic Eastern Edition
British Nursing Index with Full Text
British Nursing Index
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
Research Library Prep

MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1557-8615
EndPage 524
ExternalDocumentID 2735005351
19056016
10_1016_j_jcrc_2007_11_008
S0883944107001955
1_s2_0_S0883944107001955
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
--K
--M
-RU
.1-
.FO
.~1
0R~
1B1
1P~
1RT
1~.
1~5
2FS
354
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
71M
7RV
7X7
88E
8FI
8FJ
8G5
8P~
9JM
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AATTM
AAWTL
AAXKI
AAXUO
AAYWO
ABBQC
ABFRF
ABJNI
ABMAC
ABMZM
ABUWG
ABWVN
ABXDB
ACDAQ
ACGFO
ACGFS
ACIEU
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADFRT
ADMUD
ADNMO
AEBSH
AEFWE
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFJKZ
AFKRA
AFPUW
AFRHN
AFTJW
AFXIZ
AGCQF
AGHFR
AGQPQ
AGUBO
AGYEJ
AHHHB
AHMBA
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
AN0
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
AZQEC
BENPR
BKEYQ
BKOJK
BLXMC
BNPGV
BNQBC
BPHCQ
BVXVI
C45
CCPQU
CS3
DU5
DWQXO
EBS
EFJIC
EFKBS
EJD
EMOBN
EO8
EO9
EP2
EP3
EX3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
FYUFA
G-2
G-Q
GBLVA
GNUQQ
GUQSH
HDV
HMCUK
HMK
HMO
HVGLF
HZ~
IHE
J1W
KOM
LX1
M1P
M29
M2O
M41
MO0
N9A
NAPCQ
O-L
O9-
OA0
OAUVE
OBH
OHH
OM-
OVD
OZT
P-8
P-9
P2P
PC.
PHGZM
PHGZT
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
PUEGO
Q38
R2-
ROL
RPZ
SAE
SDF
SDG
SEL
SES
SEW
SPCBC
SSH
SSZ
SV3
T5K
TEORI
UKHRP
UNMZH
UV1
WHG
WOW
WUQ
Z5R
ZB8
ZGI
ZY1
~G-
3V.
AACTN
AFCTW
AFKWA
AJOXV
ALIPV
AMFUW
RIG
AAIAV
ABLVK
ABYKQ
AFDAS
AJBFU
EFLBG
LCYCR
AAYXX
AGRNS
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7XB
8FK
ASE
FPQ
K6X
K9.
MBDVC
PKEHL
PQEST
PQUKI
Q9U
7X8
ID FETCH-LOGICAL-c488t-c8a9635768a5d84041baca8665716b522806fbdf5f84de98a6567f7f243bcbd33
IEDL.DBID .~1
ISSN 0883-9441
1557-8615
IngestDate Fri Jul 11 00:07:51 EDT 2025
Sat Aug 23 14:02:18 EDT 2025
Thu Apr 03 06:58:12 EDT 2025
Thu Apr 24 23:04:15 EDT 2025
Tue Jul 01 03:14:17 EDT 2025
Fri Feb 23 02:22:23 EST 2024
Sun Feb 23 10:19:23 EST 2025
Tue Aug 26 16:32:07 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Human
Interleukin-4
Sepsis
Interleukin-4 δ2
Cytokines
Language English
License https://www.elsevier.com/tdm/userlicense/1.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c488t-c8a9635768a5d84041baca8665716b522806fbdf5f84de98a6567f7f243bcbd33
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Undefined-1
ObjectType-Feature-3
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
PMID 19056016
PQID 1033237386
PQPubID 1226342
PageCount 6
ParticipantIDs proquest_miscellaneous_69870920
proquest_journals_1033237386
pubmed_primary_19056016
crossref_citationtrail_10_1016_j_jcrc_2007_11_008
crossref_primary_10_1016_j_jcrc_2007_11_008
elsevier_sciencedirect_doi_10_1016_j_jcrc_2007_11_008
elsevier_clinicalkeyesjournals_1_s2_0_S0883944107001955
elsevier_clinicalkey_doi_10_1016_j_jcrc_2007_11_008
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2008-12-01
PublicationDateYYYYMMDD 2008-12-01
PublicationDate_xml – month: 12
  year: 2008
  text: 2008-12-01
  day: 01
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Philadelphia
PublicationTitle Journal of critical care
PublicationTitleAlternate J Crit Care
PublicationYear 2008
Publisher Elsevier Inc
Elsevier Limited
Publisher_xml – name: Elsevier Inc
– name: Elsevier Limited
References Glare, Divjak, Bailey (bib17) 2001; 56
Reddy, Chen, Tekchandani (bib2) 2001; 24
Levy, Fink, Marshall (bib7) 2003; 31
Knaus, Draper, Wagner (bib8) 1985; 13
Hynninen, Pettila, Takkunen (bib20) 2003; 20
Fujitsu, Fukuda, Kumagai (bib3) 2003; 76
Alms, Atamas, Yurovsky (bib15) 1996; 33
Baumhofer, Beinhauer, Wang (bib10) 1998; 28
Marshall, Cook, Christou (bib9) 1995; 23
Russell (bib6) 2006; 355
Headley, Tolley, Meduri (bib19) 1997; 111
Hultgren, Kopf, Tarkowski (bib13) 1999; 29
Seah, Gao, Hopkin (bib16) 2001; 164
Dheda, Chang, Huggett (bib21) 2007; 87
Hotchkiss, Karl (bib1) 2003; 348
Atamas, Choi, Yurovsky (bib4) 1996; 156
Demissie, Abebe, Aseffa (bib14) 2004; 172
Hess, Henry-Stanley, Erickson (bib11) 2002; 104
Arinobu, Atamas, Otsuka (bib5) 1999; 191
DiPiro, Howdieshell, Goddard (bib18) 1995; 130
Song, Chung, Chaudry (bib12) 2000; 128
Dheda (10.1016/j.jcrc.2007.11.008_bib21) 2007; 87
Arinobu (10.1016/j.jcrc.2007.11.008_bib5) 1999; 191
Hultgren (10.1016/j.jcrc.2007.11.008_bib13) 1999; 29
Knaus (10.1016/j.jcrc.2007.11.008_bib8) 1985; 13
Hess (10.1016/j.jcrc.2007.11.008_bib11) 2002; 104
Hotchkiss (10.1016/j.jcrc.2007.11.008_bib1) 2003; 348
Reddy (10.1016/j.jcrc.2007.11.008_bib2) 2001; 24
Fujitsu (10.1016/j.jcrc.2007.11.008_bib3) 2003; 76
Marshall (10.1016/j.jcrc.2007.11.008_bib9) 1995; 23
Alms (10.1016/j.jcrc.2007.11.008_bib15) 1996; 33
Glare (10.1016/j.jcrc.2007.11.008_bib17) 2001; 56
Song (10.1016/j.jcrc.2007.11.008_bib12) 2000; 128
Baumhofer (10.1016/j.jcrc.2007.11.008_bib10) 1998; 28
Seah (10.1016/j.jcrc.2007.11.008_bib16) 2001; 164
Headley (10.1016/j.jcrc.2007.11.008_bib19) 1997; 111
Hynninen (10.1016/j.jcrc.2007.11.008_bib20) 2003; 20
DiPiro (10.1016/j.jcrc.2007.11.008_bib18) 1995; 130
Atamas (10.1016/j.jcrc.2007.11.008_bib4) 1996; 156
Russell (10.1016/j.jcrc.2007.11.008_bib6) 2006; 355
Levy (10.1016/j.jcrc.2007.11.008_bib7) 2003; 31
Demissie (10.1016/j.jcrc.2007.11.008_bib14) 2004; 172
References_xml – volume: 29
  start-page: 2400
  year: 1999
  end-page: 2405
  ident: bib13
  article-title: Outcome of Staphylococcus aureus-triggered sepsis and arthritis in IL-4–deficient mice depends on the genetic background of the host
  publication-title: Eur J Immunol
– volume: 87
  start-page: 237
  year: 2007
  end-page: 241
  ident: bib21
  article-title: The stability of mRNA encoding IL-4 is increased in pulmonary tuberculosis, while stability of mRNA encoding the antagonistic splice variant, IL-4delta2, is not
  publication-title: Tuberculosis
– volume: 20
  start-page: 1
  year: 2003
  end-page: 4
  ident: bib20
  article-title: Predictive value of monocyte histocompatibility leukocyte antigen-DR expression and plasma interleukin-4 and -10 levels in critically ill patients with sepsis
  publication-title: Shock
– volume: 24
  start-page: 273
  year: 2001
  end-page: 287
  ident: bib2
  article-title: Sepsis-induced immunosuppression: from bad to worse
  publication-title: Immunol Res
– volume: 13
  start-page: 818
  year: 1985
  end-page: 829
  ident: bib8
  article-title: APACHE II: a severity of disease classification system
  publication-title: Crit Care Med
– volume: 191
  start-page: 161
  year: 1999
  end-page: 167
  ident: bib5
  article-title: Antagonistic effects of an alternative splice variant of human IL-4, IL-4delta2, on IL-4 activities in human monocytes and B cells
  publication-title: Cell Immunol
– volume: 76
  start-page: 107
  year: 2003
  end-page: 114
  ident: bib3
  article-title: IL-4–induced cell proliferation and production of extracellular matrix proteins in human conjunctival fibroblasts
  publication-title: Exp Eye Res
– volume: 104
  start-page: 88
  year: 2002
  end-page: 94
  ident: bib11
  article-title: Effect of tumor necrosis factor alpha, interferon gamma, and interleukin-4 on bacteria-enterocyte interactions
  publication-title: J Surg Res
– volume: 355
  start-page: 1699
  year: 2006
  end-page: 1713
  ident: bib6
  article-title: Management of sepsis
  publication-title: N Engl J Med
– volume: 130
  start-page: 1159
  year: 1995
  end-page: 1162
  ident: bib18
  article-title: Association of interleukin-4 plasma levels with traumatic injury and clinical course
  publication-title: Arch Surg
– volume: 31
  start-page: 1250
  year: 2003
  end-page: 1256
  ident: bib7
  article-title: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
  publication-title: Crit Care Med
– volume: 128
  start-page: 133
  year: 2000
  end-page: 138
  ident: bib12
  article-title: IL-4–induced activation of the Stat6 pathway contributes to the suppression of cell-mediated immunity and death in sepsis
  publication-title: Surgery
– volume: 28
  start-page: 610
  year: 1998
  end-page: 615
  ident: bib10
  article-title: Gene transfer with IL-4 and IL-13 improves survival in lethal endotoxemia in the mouse and ameliorates peritoneal macrophages immune competence
  publication-title: Eur J Immunol
– volume: 33
  start-page: 361
  year: 1996
  end-page: 370
  ident: bib15
  article-title: Generation of a variant of human interleukin-4 by alternative splicing
  publication-title: Mol Immunol
– volume: 164
  start-page: 1016
  year: 2001
  end-page: 1018
  ident: bib16
  article-title: Interleukin-4 and its alternatively spliced variant (IL-4delta2) in patients with atopic asthma
  publication-title: Am J Respir Crit Care Med
– volume: 56
  start-page: 541
  year: 2001
  end-page: 548
  ident: bib17
  article-title: The usefulness of competitive PCR: airway gene expression of IL-5, IL-4, IL-4delta2, IL-2, and IFNgamma in asthma
  publication-title: Thorax
– volume: 348
  start-page: 138
  year: 2003
  end-page: 150
  ident: bib1
  article-title: The pathophysiology and treatment of sepsis
  publication-title: N Engl J Med
– volume: 156
  start-page: 435
  year: 1996
  end-page: 441
  ident: bib4
  article-title: An alternative splice variant of human IL-4, IL-4 delta 2, inhibits IL-4–stimulated T cell proliferation
  publication-title: J Immunol
– volume: 111
  start-page: 1306
  year: 1997
  end-page: 1321
  ident: bib19
  article-title: Infections and the inflammatory response in acute respiratory distress syndrome
  publication-title: Chest
– volume: 23
  start-page: 1638
  year: 1995
  end-page: 1652
  ident: bib9
  article-title: Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome
  publication-title: Crit Care Med
– volume: 172
  start-page: 6938
  year: 2004
  end-page: 6943
  ident: bib14
  article-title: Healthy individuals that control a latent infection with Mycobacterium tuberculosis express high levels of T
  publication-title: J Immunol
– volume: 13
  start-page: 818
  issue: 10
  year: 1985
  ident: 10.1016/j.jcrc.2007.11.008_bib8
  article-title: APACHE II: a severity of disease classification system
  publication-title: Crit Care Med
  doi: 10.1097/00003246-198510000-00009
– volume: 164
  start-page: 1016
  issue: 6
  year: 2001
  ident: 10.1016/j.jcrc.2007.11.008_bib16
  article-title: Interleukin-4 and its alternatively spliced variant (IL-4delta2) in patients with atopic asthma
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/ajrccm.164.6.2012138
– volume: 191
  start-page: 161
  issue: 2
  year: 1999
  ident: 10.1016/j.jcrc.2007.11.008_bib5
  article-title: Antagonistic effects of an alternative splice variant of human IL-4, IL-4delta2, on IL-4 activities in human monocytes and B cells
  publication-title: Cell Immunol
  doi: 10.1006/cimm.1998.1431
– volume: 355
  start-page: 1699
  issue: 16
  year: 2006
  ident: 10.1016/j.jcrc.2007.11.008_bib6
  article-title: Management of sepsis
  publication-title: N Engl J Med
  doi: 10.1056/NEJMra043632
– volume: 33
  start-page: 361
  issue: 4–5
  year: 1996
  ident: 10.1016/j.jcrc.2007.11.008_bib15
  article-title: Generation of a variant of human interleukin-4 by alternative splicing
  publication-title: Mol Immunol
  doi: 10.1016/0161-5890(95)00154-9
– volume: 156
  start-page: 435
  issue: 2
  year: 1996
  ident: 10.1016/j.jcrc.2007.11.008_bib4
  article-title: An alternative splice variant of human IL-4, IL-4 delta 2, inhibits IL-4–stimulated T cell proliferation
  publication-title: J Immunol
  doi: 10.4049/jimmunol.156.2.435
– volume: 172
  start-page: 6938
  issue: 11
  year: 2004
  ident: 10.1016/j.jcrc.2007.11.008_bib14
  article-title: Healthy individuals that control a latent infection with Mycobacterium tuberculosis express high levels of TH1 cytokines and the IL-4 antagonist IL-4delta2
  publication-title: J Immunol
  doi: 10.4049/jimmunol.172.11.6938
– volume: 24
  start-page: 273
  issue: 3
  year: 2001
  ident: 10.1016/j.jcrc.2007.11.008_bib2
  article-title: Sepsis-induced immunosuppression: from bad to worse
  publication-title: Immunol Res
  doi: 10.1385/IR:24:3:273
– volume: 128
  start-page: 133
  issue: 2
  year: 2000
  ident: 10.1016/j.jcrc.2007.11.008_bib12
  article-title: IL-4–induced activation of the Stat6 pathway contributes to the suppression of cell-mediated immunity and death in sepsis
  publication-title: Surgery
  doi: 10.1067/msy.2000.107282
– volume: 28
  start-page: 610
  issue: 2
  year: 1998
  ident: 10.1016/j.jcrc.2007.11.008_bib10
  article-title: Gene transfer with IL-4 and IL-13 improves survival in lethal endotoxemia in the mouse and ameliorates peritoneal macrophages immune competence
  publication-title: Eur J Immunol
  doi: 10.1002/(SICI)1521-4141(199802)28:02<610::AID-IMMU610>3.0.CO;2-5
– volume: 104
  start-page: 88
  issue: 2
  year: 2002
  ident: 10.1016/j.jcrc.2007.11.008_bib11
  article-title: Effect of tumor necrosis factor alpha, interferon gamma, and interleukin-4 on bacteria-enterocyte interactions
  publication-title: J Surg Res
  doi: 10.1006/jsre.2002.6417
– volume: 87
  start-page: 237
  issue: 3
  year: 2007
  ident: 10.1016/j.jcrc.2007.11.008_bib21
  article-title: The stability of mRNA encoding IL-4 is increased in pulmonary tuberculosis, while stability of mRNA encoding the antagonistic splice variant, IL-4delta2, is not
  publication-title: Tuberculosis
  doi: 10.1016/j.tube.2006.11.001
– volume: 348
  start-page: 138
  issue: 2
  year: 2003
  ident: 10.1016/j.jcrc.2007.11.008_bib1
  article-title: The pathophysiology and treatment of sepsis
  publication-title: N Engl J Med
  doi: 10.1056/NEJMra021333
– volume: 76
  start-page: 107
  issue: 1
  year: 2003
  ident: 10.1016/j.jcrc.2007.11.008_bib3
  article-title: IL-4–induced cell proliferation and production of extracellular matrix proteins in human conjunctival fibroblasts
  publication-title: Exp Eye Res
  doi: 10.1016/S0014-4835(02)00248-8
– volume: 31
  start-page: 1250
  issue: 4
  year: 2003
  ident: 10.1016/j.jcrc.2007.11.008_bib7
  article-title: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
  publication-title: Crit Care Med
  doi: 10.1097/01.CCM.0000050454.01978.3B
– volume: 111
  start-page: 1306
  issue: 5
  year: 1997
  ident: 10.1016/j.jcrc.2007.11.008_bib19
  article-title: Infections and the inflammatory response in acute respiratory distress syndrome
  publication-title: Chest
  doi: 10.1378/chest.111.5.1306
– volume: 56
  start-page: 541
  issue: 7
  year: 2001
  ident: 10.1016/j.jcrc.2007.11.008_bib17
  article-title: The usefulness of competitive PCR: airway gene expression of IL-5, IL-4, IL-4delta2, IL-2, and IFNgamma in asthma
  publication-title: Thorax
  doi: 10.1136/thorax.56.7.541
– volume: 20
  start-page: 1
  issue: 1
  year: 2003
  ident: 10.1016/j.jcrc.2007.11.008_bib20
  article-title: Predictive value of monocyte histocompatibility leukocyte antigen-DR expression and plasma interleukin-4 and -10 levels in critically ill patients with sepsis
  publication-title: Shock
  doi: 10.1097/01.shk.0000068322.08268.b4
– volume: 29
  start-page: 2400
  issue: 8
  year: 1999
  ident: 10.1016/j.jcrc.2007.11.008_bib13
  article-title: Outcome of Staphylococcus aureus-triggered sepsis and arthritis in IL-4–deficient mice depends on the genetic background of the host
  publication-title: Eur J Immunol
  doi: 10.1002/(SICI)1521-4141(199908)29:08<2400::AID-IMMU2400>3.0.CO;2-E
– volume: 23
  start-page: 1638
  issue: 10
  year: 1995
  ident: 10.1016/j.jcrc.2007.11.008_bib9
  article-title: Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome
  publication-title: Crit Care Med
  doi: 10.1097/00003246-199510000-00007
– volume: 130
  start-page: 1159
  issue: 11
  year: 1995
  ident: 10.1016/j.jcrc.2007.11.008_bib18
  article-title: Association of interleukin-4 plasma levels with traumatic injury and clinical course
  publication-title: Arch Surg
  doi: 10.1001/archsurg.1995.01430110017004
SSID ssj0017335
Score 1.9794198
Snippet Sepsis is a complicated syndrome in which proinflammatory and anti-inflammatory cytokines are expressed simultaneously. However, it remains unclear for the...
Abstract Purpose Sepsis is a complicated syndrome in which proinflammatory and anti-inflammatory cytokines are expressed simultaneously. However, it remains...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 519
SubjectTerms Aged
Annealing
Critical Care
Cytokines
Enzyme-Linked Immunosorbent Assay
Female
Glyceraldehyde-3-Phosphate Dehydrogenases - blood
Hospitals
Human
Humans
Intensive care
Interleukin-4
Interleukin-4 - biosynthesis
Interleukin-4 δ2
Leukocytes, Mononuclear - metabolism
Lymphocytes
Male
Personal relationships
Plasma
Polymerase chain reaction
Prospective Studies
Proteins
Reverse Transcriptase Polymerase Chain Reaction
RNA, Messenger - biosynthesis
Sepsis
Sepsis - blood
Tuberculosis
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1LS8QwEB50BfEivq3PHrxJod0kTYsHEVFE0IsKewtpmoAPuut2F_z5zrRpveh66iGdBCaTyUwy-T6AM2d4UlpMU4UTJuLaEhtgHEdFKXFDcILlnF4jPzymdy_8fiRG_sCt9mWVnU9sHHU5NnRGjqubsSHB8KSXk8-IWKPodtVTaCzDCkGXkVXLUZ9wJZK1BJtZxqIc933_aKat73ozUw9hSCieRC_5-8b0V-DZbEC3G7DuI8fwqp3qTViy1RasPvi78W24wBkPCf1h-mHn769VxEP75ctcK2wIPYRqHdLZa4gD26nFz6R-rXfg5fbm-fou8tQIkcEVN4tMpnNCkkszLUrM0XhSaKMJuw7zn0IQxk3qitIJl_HS5pnGsE066YacFaYoGduFQTWu7D6EXDAjNUZaRhAleJw57DvW0rCC55ktA0g6vSjjccOJvuJDdQVib4p0SYSWEhMKhboM4LyXmbSoGQv_Zp26VfceFD2YQqe-UEr-JmVrvwhrlah6qGL1RPNP0x_L5nmkCED0kj7OaOOHf0c86mxB_QzS22UAp30zrlG6eNGVHc9rleboFfNhHMBea0E_SsljSonTg8VdH8JaU6fSlNEcwWA2ndtjDIZmxUlj8d89wwTG
  priority: 102
  providerName: ProQuest
Title The interleukin-4 expression in patients with severe sepsis
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0883944107001955
https://www.clinicalkey.es/playcontent/1-s2.0-S0883944107001955
https://dx.doi.org/10.1016/j.jcrc.2007.11.008
https://www.ncbi.nlm.nih.gov/pubmed/19056016
https://www.proquest.com/docview/1033237386
https://www.proquest.com/docview/69870920
Volume 23
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dT9swED8hJiFe0AYDsjGWB95Q1qS240R7YhWofFWIDalvluPYUhkKVdNKPPG37y5xitAYSHuJpcSOrcvd-S6--x3AgTM8KS26qcIJE3FtqRpgHEdFKXFDcILlnLKRL0fp8IafjcV4BQZdLgyFVXrd3-r0Rlv7Oz1Pzd50Mun9RPmgrE70X5qsN0o051wSl397XIZ5JJK1RTaxc0S9feJMG-N1a2YexpCQPKnE5Mub07-Mz2YTOnkPG956DI_aBX6AFVttwtqlPx_fgu_41UNCgJjd2cXvSRXx0D74UNcKH4QeRrUO6f9riBPbmcVmWk_qj3BzcvxrMIx8eYTIoNTNI5PpnNDk0kyLEv00nhTaaMKvQx-oEIRzk7qidMJlvLR5ptF0k066PmeFKUrGtmG1uq_sLoRcMCM1WltGUFnwOHP47lhLwwqeZ7YMIOnooozHDqcSFneqCxK7VURLKmop0alQSMsADpdjpi1yxqu9WUdu1eWEohZTqNhfHSVfGmVrL4i1SlTdV7H6i1kCEMuRz_jtzRn3Ol5QT5PEjPUJIioN4OvyMcopHb7oyt4vapXmqBnzfhzATstBT0TJY3KL00__uaTPsN4EsTQxNnuwOp8t7Be0lObFfiMKeJVjuQ_vjgbXF1fUnp4PR9j-OB5dXf8Bv1oTTA
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB5VRQIuiHcDheYAJxTJie04EUIIAdWWdnuhlfZmHMeWWqrsstlVy5_iNzKTOOmlLKeeckgcS-PxPOyZ7wN4461Ia4dpqvTSJsI4YgNkLKlqhQ7BS14K6kaeHueTU_FtJmdb8GfohaGyysEmdoa6nls6I8fdzXlGMDz5x8WvhFij6HZ1oNDo1eLQ_b7ElK39cPAF1_dtlu1_Pfk8SQKrQGJRWVeJLUxJIGx5YWSN6Y1IK2MNwb5h6lBJgofJfVV76QtRu7IwGPEor3wmeGWrmg5A0eTfQcfLKNlTszHBSxXvCT2LgiclxhmhSaevJzu3ywCZSKihRGd5syP8V6DbObz9h_AgRKrxp161HsGWax7D3Wm4i38C71HDYkKbWF649c-zJhGxuwpltQ2-iANkaxvTWW-ME7ulw8eiPWufwumtCO0ZbDfzxu1ALCS3ymBkZyVRkLPC47-ZUZZXoixcHUE6yEXbgFNOdBkXeihIO9ckSyLQVJjAaJRlBO_GMYsepWPj13wQtx76T9FianQiG0epm0a5Nmz6Vqe6zTTT32n9afmZ6toxZQRyHBnimj5e-e-Mu4Mu6OtJxn0Qwd74Gm0CXfSYxs3Xrc5LtMJlxiJ43mvQtVBKRil4_mLzr_fg3uRkeqSPDo4PX8L9rkamK-HZhe3Vcu1eYSC2ql532h_Dj9vebn8BnkZBSw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LT9wwEB6hRUK9VJS-Qink0J5Q1Gxsx4mqqmoLKyiwQm2RuLmOY0s8lN1udlX4a_11nUmccKHbE6ccHNvSeDyesWe-D-CNM3xYWgxThRMm4toSG2AcR0Up8UBwguWcqpFPxunBGf96Ls5X4E9XC0NplZ1NbAx1OTF0R467m7GEYHjSd86nRZzujT5Of0XEIEUvrR2dRqsiR_b2N4Zv9YfDPVzrt0ky2v_x5SDyDAORQcWdRybTOQGypZkWJYY6fFhoowkCDsOIQhBUTOqK0gmX8dLmmUbvRzrpEs4KU5R0GYrmf1VSVDSA1c_749Nv_RuGZC29Z5axKEevw5fstNlll2bmARQJQ5TILe8_Fv_l9jbH32gdHnu_NfzUKtoTWLHVBqyd-Jf5p_Ae9S0k7InZtV1cXVQRD-2NT7KtsCH0AK51SDe_IU5sZxY_0_qifgZnDyK25zCoJpV9CSEXzEiNfp4RREgeZw7HjrU0rOB5ZssAhp1clPGo5USeca269LRLRbIkOk2J4YxCWQaw2_eZtpgdS_9mnbhVV42K9lPhkbK0l7yvl629CajVUNWJitV3Wn9a_lg2xZkiANH39F5O6738d8atThfU3ST9rghgp29GC0HPPrqyk0Wt0hxtcp7EAbxoNehOKHlMAXm6uXzoHVjDraaOD8dHr-BRkzDT5PNswWA-W9jX6JXNi22v_iH8fOgd9xdIbUbm
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+interleukin-4+expression+in+patients+with+severe+sepsis&rft.jtitle=Journal+of+critical+care&rft.au=Wu%2C+Huang-Pin&rft.au=Wu%2C+Chia-Ling&rft.au=Chen%2C+Chian-Kuang&rft.au=Chung%2C+Kong&rft.date=2008-12-01&rft.pub=Elsevier+Inc&rft.issn=0883-9441&rft.eissn=1557-8615&rft.volume=23&rft.issue=4&rft.spage=519&rft.epage=524&rft_id=info:doi/10.1016%2Fj.jcrc.2007.11.008&rft.externalDocID=S0883944107001955
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F08839441%2FS0883944108X0005X%2Fcov150h.gif